Tygh Capital Management, Inc. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tygh Capital Management, Inc. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2021$3,848,000
+4.1%
35,924
-0.0%
0.49%
-1.6%
Q3 2021$3,695,000
+26.2%
35,940
+8.0%
0.50%
+25.3%
Q2 2021$2,927,000
-10.5%
33,274
-1.0%
0.40%
-13.6%
Q1 2021$3,269,000
-9.8%
33,622
+4.1%
0.46%
-18.1%
Q4 2020$3,623,000
+20.9%
32,303
-0.1%
0.56%
-0.7%
Q3 2020$2,996,00032,3220.57%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders